FLT3-ITD mutations are prevalent and significantly impact outcome after intensive therapy in elderly adults with acute myeloid leukemia (AML): Analysis of the North American Intergroup E2906 phase III trial in patients age ≥ 60 years Meeting Abstract
| Authors: | Foran, J. M.; Sun, Z.; Paietta, E.; Racevskis, J.; Claxton, D. F.; Lazarus, H. M.; Arber, D. A.; Rowe, J. M.; Godwin, J.; Zhang, Y.; Tallman, M. S.; Litzow, M. R.; Pratz, K. W.; Luger, S. |
| Abstract Title: | FLT3-ITD mutations are prevalent and significantly impact outcome after intensive therapy in elderly adults with acute myeloid leukemia (AML): Analysis of the North American Intergroup E2906 phase III trial in patients age ≥ 60 years |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842803031 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-117838 |
| Notes: | Meeting Abstract: 3995 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
